Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FDA Approval of Desmopressin for Nocturia.

× No keyword cloud information.

8 in total

Review 1. [Treatment of nocturia in men with desmopressin].

Authors: S Mühlstädt
Journal: Urologe A Date: 2018-04 Impact factor: 0.639

2. Pharmaceutical Marketing at the 2018 American Geriatrics Society Annual Scientific Meeting: The Case of Noctiva and the Need for Increased Vigilance.

Authors: Jerry H Gurwitz
Journal: J Am Geriatr Soc Date: 2018-10-05 Impact factor: 5.562

3. Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.

Authors: Brian D Gonzalez; Brent J Small; Mallory G Cases; Noelle L Williams; Mayer N Fishman; Paul B Jacobsen; Heather S L Jim
Journal: Cancer Date: 2017-10-26 Impact factor: 6.860

Review 4. Desmopressin for treating nocturia in men.

Authors: Julia Han; Jae Hung Jung; Caitlin J Bakker; Mark H Ebell; Philipp Dahm
Journal: Cochrane Database Syst Rev Date: 2017-10-21

5. Comorbidities, Age, and Polypharmacy Limit the Use by US Older Adults with Nocturia of the Only FDA-approved Drugs for the Symptom.

Authors: Kara Suvada; Laura Plantinga; Camille P Vaughan; Alayne D Markland; Anna Mirk; Kathryn L Burgio; Susanne M Erni; Mohammed K Ali; Ike Okosun; Henry Young; Patricia S Goode; Theodore M Johnson
Journal: Clin Ther Date: 2020-11-28 Impact factor: 3.393

FDA Approval of Desmopressin for Nocturia.

Review 1. [Treatment of nocturia in men with desmopressin].

2. Pharmaceutical Marketing at the 2018 American Geriatrics Society Annual Scientific Meeting: The Case of Noctiva and the Need for Increased Vigilance.

3. Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.

Review 4. Desmopressin for treating nocturia in men.

5. Comorbidities, Age, and Polypharmacy Limit the Use by US Older Adults with Nocturia of the Only FDA-approved Drugs for the Symptom.

6. Desmopressin and the risk of hyponatremia: A population-based cohort study.

Review 7. Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases.

Review 8. Use of Desmopressin in Hyponatremia: Foe and Friend.